Shenzhen Basda Medical Co., Ltd. & Hongbang Technology Co., Ltd.
(Strategic Partnership since 2019)
🔸 2000–2018: Technological Foundation & Breakthroughs
- 2000 — Shenzhen Basda Medical Co., Ltd. was established, initiating R&D in MRI technology.
- 2005–2010 — Successful launch of early models including BTI-035, Bstar-050, and Bstar-300, with national registrations and CE certification obtained.
- 2011–2015 — Product portfolio expanded to include nuclear medicine, ultrasound, and linear accelerators.
The company was listed on the National Equities Exchange (Stock Code: 833638). - 2016–2018 — Major technological breakthroughs achieved, including:
- Helium-free MRI technology
- Open MRI systems
- High-field 3.0T MRI systems
Construction of Basda Industrial Park completed, with multiple national and provincial recognitions.
🔸 2019: Strategic Partnership & Global Expansion
- Hongbang Technology Co., Ltd. officially became the strategic partner of Basda Medical for international markets.
- Core models such as Bstar-150 Plus and BTI-030/035/042/050 were included in China’s high-quality domestic equipment catalog.
- Recognitions:
- Top 100 Innovative Enterprises in Guangdong
- Top 500 Enterprises in Shenzhen
🔸 2020: Strengthening Innovation
- Breakthrough development of helium-free MRI systems with zero consumables.
- Over 10 new registrations obtained for MRI and ECG systems.
- Recognized as a key enterprise in Shenzhen.
- Awarded Shenzhen Bio Industry Innovation Award.
- Achieved the 5th National High-Tech Enterprise certification.
🔸 2021: Continuous Innovation & Market Recognition
- Obtained 19 registrations for ultrasound and X-ray systems.
- The 0.52T MRI system recognized as an innovative product in Guangdong Province.
- Included in China’s catalog of high-quality domestic medical devices.
- Basda Industrial Design Center recognized at the provincial level.
🔸 2022: Expansion & Digital Transformation
- Major upgrades of MRI product lines including Bstar-300, BTI-070, and Bstar-149.
- Integration of PACS, cloud diagnostics, and AI solutions.
- Development of specialized MRI systems for joint imaging and pediatric applications.
- Strengthened cooperation with leading universities including
Peking University, SCUT, and Harbin Institute of Technology.
🔸 2023: Globalization & Large-Scale Registration
- Jointly with Hongbang Technology, products were registered across
Kazakhstan, Kyrgyzstan, Uzbekistan, Turkmenistan, and other CIS countries. - Launch of mobile diagnostic solutions (MRI & CT vehicles) for remote regions.
- Successful deployment of 1.5T helium-free MRI systems in overseas hospitals.
- Development of AI-based imaging analysis and remote diagnostics platforms.
- Participation in major international exhibitions:
- Arab Health
- Medlab
- Zdravookhraneniye (Russia)
- Establishment of overseas training centers for engineers and clinicians.
🔸 2024: Intelligent Systems & Market Breakthrough
- Launch of flagship Bstar-300X 3.0T MRI system with AI-guided imaging and energy-efficient design.
- Deployment of a Central Asia teleradiology platform connecting hospitals across multiple countries.
- Establishment of international regulatory and project centers supporting CE, EAEU, GOST certifications.
- Introduction of compact diagnostic solutions integrating ultrasound, ECG, and X-ray.
- Secured multiple government contracts under the Belt and Road Initiative.
- Expanded into Eastern European hospital procurement systems, achieving market entry beyond the EU.
🔸 Looking Ahead
Shenzhen Basda Medical Co., Ltd. and Hongbang Technology Co., Ltd. will continue to strengthen industrial and scientific collaboration, driving innovation in MRI, CT, ultrasound, radiotherapy, telemedicine, and AI technologies.
👉 We are committed to positioning Chinese medical technology as a global leader, delivering intelligent, accessible, and high-quality healthcare solutions worldwide.